Page last updated: 2024-11-05

tripelennamine and Chickenpox

tripelennamine has been researched along with Chickenpox in 3 studies

Tripelennamine: A histamine H1 antagonist with low sedative action but frequent gastrointestinal irritation. It is used to treat ASTHMA; HAY FEVER; URTICARIA; and RHINITIS; and also in veterinary applications. Tripelennamine is administered by various routes, including topically.

Chickenpox: A highly contagious infectious disease caused by the varicella-zoster virus (HERPESVIRUS 3, HUMAN). It usually affects children, is spread by direct contact or respiratory route via droplet nuclei, and is characterized by the appearance on the skin and mucous membranes of successive crops of typical pruritic vesicular lesions that are easily broken and become scabbed. Chickenpox is relatively benign in children, but may be complicated by pneumonia and encephalitis in adults. (From Dorland, 27th ed)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19903 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
KALMANSOHN, RB1
CARNEIRO, O1
SILVERMAN, LB1

Other Studies

3 other studies available for tripelennamine and Chickenpox

ArticleYear
Tripelennamine in varicella.
    United States Armed Forces medical journal, 1953, Volume: 4, Issue:6

    Topics: Chickenpox; Humans; Tripelennamine

1953
[Anti-pruriginous effect of antihistamines in chickenpox].
    Folha medica, 1952, Mar-25, Volume: 33, Issue:6

    Topics: Anti-Allergic Agents; Chickenpox; Histamine Antagonists; Tripelennamine

1952
The treatment of pruritus from chicken pox with pyribenzamine.
    The Journal of pediatrics, 1949, Volume: 35, Issue:4

    Topics: Chickenpox; Pruritus; Tripelennamine

1949